Clinical trial
Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine After Concomitant Vaccination in ≥50-year-old Adults
NCT03552445 is registered in ClinicalTrials.gov with Korea University Guro Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine After Concomitant Vaccination in ≥50-year-old Adults
- Lead sponsor
- Korea University Guro Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 1, 2013
- Completion date
- February 28, 2018
- Enrollment
- 462 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.